Madi Lama, Alsaad Doua, Khawaja Raja Al, Kassem Wessam El, Hail Moza Al
Department of Pharmacy, Qatar Rehabilitation Institute, Hamad Medical Corporation, Doha, Qatar.
Department of Pharmacy, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
Pharm Pract (Granada). 2022 Oct-Dec;20(4):2646. doi: 10.18549/PharmPract.2022.4.2646. Epub 2022 Oct 6.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gained global attention because of its high transmissibility and the devastating impact on both clinical and economic outcomes. Pharmacists are among the front-line healthcare workers who contributed widely to COVID-19 pandemic control. We aim to evaluate knowledge and attitude of hospital pharmacists in Qatar about COVID-19.
A descriptive cross-sectional web-based survey was distributed over a 2-months period. The study included pharmacists who are working in 10 different hospitals under Hamad Medical Corporation (HMC). The survey was developed based on information available at World Health Organization (WHO) website, Qatar Ministry of Health, and COVID-19 guideline created by HMC. The study was approved by HMC's institutional review board (MRC-01-20-1009). Data analysis was done using SPSS version 22.
A total of 187 pharmacists were included (response rate 33%). The overall level of knowledge was not affected by the participants' demographics (p-value ≥0.05). Pharmacists provided more correct answers to questions related to general knowledge about COVID-19 compared to questions specificto treatment aspects of the disease. More than 50% of pharmacists were using national resources as main source of information related to COVID-19. Good health practices and attitudes regarding disease control was reported by pharmacists, including preventive measures implementation and self-isolation when needed. Around 80% of pharmacists are in favor of taking influenza vaccine and COVID-19 vaccine.
Overall, hospital pharmacists' knowledge about COVID-19 is good in relation to the disease nature and transmission. Knowledge about treatment aspects including medications needs further enhancement. Providing continuing professional development activities regarding latest information about COVID-19 and its management, and serial newsletters updates, and encouraging journal club activities for recently published research can help improve hospital pharmacist knowledge.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）因其高传播性以及对临床和经济后果的毁灭性影响而受到全球关注。药剂师是在控制2019冠状病毒病大流行中做出广泛贡献的一线医护人员之一。我们旨在评估卡塔尔医院药剂师对2019冠状病毒病的知识和态度。
在两个月的时间内进行了一项基于网络的描述性横断面调查。该研究纳入了在哈马德医疗公司（HMC）下属10家不同医院工作的药剂师。该调查是根据世界卫生组织（WHO）网站、卡塔尔卫生部以及HMC制定的2019冠状病毒病指南中的信息编制的。该研究获得了HMC机构审查委员会（MRC-01-20-1009）的批准。使用SPSS 22版进行数据分析。
共纳入187名药剂师（回复率33%）。知识的总体水平不受参与者人口统计学特征的影响（p值≥0.05）。与关于该疾病治疗方面的问题相比，药剂师对与2019冠状病毒病一般知识相关问题的回答更正确。超过50%的药剂师将国家资源作为与2019冠状病毒病相关信息的主要来源。药剂师报告了关于疾病控制的良好健康习惯和态度，包括实施预防措施以及在需要时自我隔离。约80%的药剂师赞成接种流感疫苗和2019冠状病毒病疫苗。
总体而言，医院药剂师对2019冠状病毒病的疾病性质和传播方面的知识掌握得较好。关于包括药物治疗在内的治疗方面的知识需要进一步加强。提供有关2019冠状病毒病最新信息及其管理的持续专业发展活动、系列时事通讯更新，并鼓励开展针对近期发表研究的期刊俱乐部活动，有助于提高医院药剂师的知识水平。
